This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erdogan, D. Articles by Muderrisoglu, H. Search for Related Content PubMed PubMed Citation Articles by Erdogan, D. Articles by Muderrisoglu, H. Related Collections Risk Factors Clinical Studies Echocardiography

(Circulation. 2007;115:593-599.)
© 2007 American Heart Association, Inc.

Hypertension

Effects of Normal Blood Pressure, Prehypertension, and Hypertension on Coronary Microvascular Function

Dogan Erdogan, MD; Ibrahim Yildirim, MD; Ozgur Ciftci, MD; Ismail Ozer, MD; Mustafa Caliskan, MD; Hakan Gullu, MD; Haldun Muderrisoglu, MD, FESC

From Baskent University, Konya Teaching and Medical Research Center, Cardiology Department (D.E., O.C., M.C., H.G., H.M.) and Internal Medicine Department, Nephrology Division (I.Y., I.O.), Konya, Turkey.

Correspondence to Dogan Erdogan, MD, Baskent University, Konya Teaching and Medical Research Center, Cardiology Department, Hoca Cihan Mah, Saray Cad, No. 1, Selcuklu, Konya, Turkey. E-mail aydoganer{at}yahoo.com or aydoganer@hotmail.com

Received July 10, 2006; accepted November 27, 2006.

Background— The assessment of coronary flow reserve (CFR) by transthoracic Doppler echocardiography has recently been introduced into clinical practice, and reduced CFR has been suggested to be a sensitive indicator of hypertensive end-organ damage; however, to date, this methodology has not been used to evaluate CFR in subjects with prehypertension. Accordingly, the present study was designed to evaluate CFR in subjects with prehypertension.

Methods and Results— We measured CFR of 40 subjects with prehypertension, 60 patients with hypertension, and 50 normotensive healthy volunteers using transthoracic Doppler echocardiography. None of the subjects had any systemic disease. Age, gender, body mass index, heart rate, lipid profiles, fasting glucose levels, and hemoglobin were similar among the 3 groups. CFR was significantly lower in the hypertension group than in the prehypertension and control groups; in addition, it was significantly lower in subjects with prehypertension than in control subjects (2.23±0.47, 2.54±0.48, and 2.91±0.53, respectively). Furthermore, we found that prehypertension (ß=–0.31, P<0.01) and hypertension (ß=–0.57, P<0.01) were significant predictors of lower CFR in a multivariable model that adjusted for other variables. CFR was significantly and inversely correlated with age (r=–0.20, P=0.01), systolic blood pressure (r=–0.51, P<0.01), diastolic blood pressure (r=–0.47, P<0.01), high-sensitivity C-reactive protein levels (r=–0.21, P=0.01), left atrium diameter (r=–0.22, P<0.01), mitral E deceleration time (r=–0.19, P=0.02), and mitral A velocity (r=–0.27, P<0.01), whereas mitral E/A ratio was significantly and positively correlated with CFR (r=0.26, P<0.01).

Conclusions— CFR is impaired in subjects with prehypertension, but this impairment is not as severe as that in hypertension.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				N. M. Kaplan Prehypertension: Is It Relevant for Nephrologists? Clin. J. Am. Soc. Nephrol., August 1, 2009; 4(8): 1381 - 1383. [Abstract] [Full Text] [PDF]

				P. Meimoun and C. Tribouilloy Non-invasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography: a magic tool for the real world Eur J Echocardiogr, July 1, 2008; 9(4): 449 - 457. [Abstract] [Full Text] [PDF]

				B. Williams The Year in Hypertension J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1803 - 1817. [Full Text] [PDF]

				L. Wang, T. Y. Wong, A. R. Sharrett, R. Klein, A. R. Folsom, and M. Jerosch-Herold Relationship Between Retinal Arteriolar Narrowing and Myocardial Perfusion: Multi-Ethnic Study of Atherosclerosis Hypertension, January 1, 2008; 51(1): 119 - 126. [Abstract] [Full Text] [PDF]